讯飞医疗科技（02506）今日盘中大涨5.72%，股价表现强劲。这一涨势或与招银国际最新发布的研究报告有关，该报告维持了对讯飞医疗的"买入"评级。
根据招银国际的分析，讯飞医疗2025年上半年业绩表现亮眼。公司实现收入3亿元人民币，同比增长30%。其中，政府端（G端）业务增长尤为显著，同比增长87%至1.4亿元。消费者端（C端）业务也保持稳健，增长10%至1亿元。公司运营效率持续改善，销售、管理及研发费用率均有下降，净亏损率显著收窄至22%。
尽管企业端（B端）业务表现低于预期，收入同比下降10%，但招银国际认为，讯飞医疗覆盖G、B、C三端需求的多元AI解决方案能够在一定程度上对冲单一板块波动，支撑公司的韧性增长。值得注意的是，招银国际考虑到B端业务的短期挑战，将2024-2026年收入复合增速预测从此前的37.9%下调至27.9%。尽管如此，分析师仍看好公司前景，将目标价定为143.59港元，这可能是推动股价上涨的重要因素之一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.